Atlas Trials

Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder

Clinical trial NCT00767871 · COMPLETED

Trial details

NCT number
NCT00767871
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Panic Disorder
Start date
2007-03-01
Primary completion
2007-08-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.